The Cigna Group (CI) – Research Analysts’ Weekly Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of The Cigna Group (NYSE: CI) in the last few weeks:

• 2/4/2025 – The Cigna Group had its price target lowered by analysts at Wells Fargo & Company from $370.00 to $341.00. They now have an “equal weight” rating on the stock.
• 2/4/2025 – The Cigna Group had its price target lowered by analysts at Truist Financial Co. from $390.00 to $375.00. They now have a “buy” rating on the stock.
• 2/3/2025 – The Cigna Group had its “overweight” rating reaffirmed by analysts at Piper Sandler. They now have a $348.00 price target on the stock, down previously from $394.00.
• 2/3/2025 – The Cigna Group had its price target lowered by analysts at UBS Group AG from $410.00 to $390.00. They now have a “buy” rating on the stock.
• 1/31/2025 – The Cigna Group had its “strong-buy” rating reaffirmed by analysts at Raymond James. They now have a $360.00 price target on the stock, down previously from $415.00.
• 1/31/2025 – The Cigna Group had its price target lowered by analysts at Stephens from $410.00 to $380.00. They now have an “overweight” rating on the stock.
• 1/31/2025 – The Cigna Group had its price target lowered by analysts at Cantor Fitzgerald from $400.00 to $350.00. They now have an “overweight” rating on the stock.
• 1/31/2025 – The Cigna Group had its price target lowered by analysts at Morgan Stanley from $403.00 to $379.00. They now have an “overweight” rating on the stock.
• 1/31/2025 – The Cigna Group had its price target lowered by analysts at Barclays PLC from $420.00 to $339.00. They now have an “overweight” rating on the stock.
• 1/31/2025 – The Cigna Group had its price target lowered by analysts at Oppenheimer Holdings Inc. from $400.00 to $375.00. They now have an “outperform” rating on the stock.
• 1/31/2025 – The Cigna Group was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating.
• 1/6/2025 – The Cigna Group had its price target lowered by analysts at Truist Financial Co. from $420.00 to $390.00. They now have a “buy” rating on the stock.

The Cigna Group Stock Up 0.4 %

The Cigna Group stock traded up $1.06 during mid-day trading on Tuesday, hitting $293.52. 1,086,618 shares of the company’s stock were exchanged, compared to its average volume of 1,838,567. The stock has a market cap of $81.64 billion, a P/E ratio of 23.98, a P/E/G ratio of 0.97 and a beta of 0.54. The stock has a 50 day moving average of $293.59 and a two-hundred day moving average of $323.84. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the prior year, the company posted $6.79 EPS. As a group, analysts anticipate that The Cigna Group will post 29.66 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be paid a $1.51 dividend. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a dividend yield of 2.06%. The ex-dividend date is Wednesday, March 5th. The Cigna Group’s dividend payout ratio is currently 45.75%.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. FMR LLC lifted its position in The Cigna Group by 2.0% during the 3rd quarter. FMR LLC now owns 14,230,397 shares of the health services provider’s stock worth $4,929,978,000 after buying an additional 279,880 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of The Cigna Group by 1.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 11,054,958 shares of the health services provider’s stock worth $3,829,880,000 after acquiring an additional 130,048 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of The Cigna Group by 0.4% during the third quarter. Geode Capital Management LLC now owns 5,855,443 shares of the health services provider’s stock valued at $2,021,563,000 after purchasing an additional 22,408 shares during the last quarter. Parnassus Investments LLC increased its holdings in shares of The Cigna Group by 2.1% in the third quarter. Parnassus Investments LLC now owns 2,922,121 shares of the health services provider’s stock valued at $1,012,340,000 after purchasing an additional 59,011 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in The Cigna Group by 2.1% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,168,959 shares of the health services provider’s stock worth $751,414,000 after purchasing an additional 44,810 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.